Moreover, recent study of Taktaz et al. [35] on AC 16 human cardiomyocytes demonstrated that treatment with TZP increased the expression and activity of SERCA2 and phosphorylated PLN and decreased the expression of PKA and CAMKII, essential modulators of calcium signalling and cardiac hypertrophy. The gene discussed is PLN; the disease is cardiac hypertrophy.